根据协议条款,若公司支付额外的期权付款,再生元制药公司可能启动针对更多靶点的研发项目。这一安排为该公司未来拓展研发管线提供了灵活性。
根据协议条款,若公司支付额外的期权付款,再生元制药公司可能启动针对更多靶点的研发项目。这一安排为该公司未来拓展研发管线提供了灵活性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.